These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7044864)

  • 1. Therapeutic evaluation of pindolol and verapamil in hypertrophic obstructive cardiomyopathy.
    Masini V; Ceci V; Malinconico U; Milazzotto F
    G Ital Cardiol; 1981; 11(11):1729-37. PubMed ID: 7044864
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and hemodynamic effects of verapamil in hypertrophic obstructive cardiomyopathy].
    Lösse B; Kuhn H; Loogen F
    Z Kardiol; 1982 Dec; 71(12):813-9. PubMed ID: 6891873
    [No Abstract]   [Full Text] [Related]  

  • 3. [Echocardiographic and electrocardiographic evaluation of the effects of propranolol and verapamil in obstructive hypertrophic cardiomyopathy].
    Crittin J; Mayor C; Bloch A
    Ann Cardiol Angeiol (Paris); 1984 Apr; 33(3):185-9. PubMed ID: 6375537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term treatment of hypertrophic non obstructive cardiomyopathy (HNCM) with verapamil (author's transl)].
    Kuhn H; Thelen U; Leuner C; Köhler E; Bluschke V
    Z Kardiol; 1980 Oct; 69(10):669-75. PubMed ID: 7192910
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects on left ventricular function of pindolol added to verapamil in hypertrophic cardiomyopathy.
    Dimitrow PP; Dubiel JS
    Am J Cardiol; 1993 Feb; 71(4):313-6. PubMed ID: 8427174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of long-term treatment with verapamil on the clinical picture and exertion tolerance in patients with hypertrophic cardiomyopathy].
    Nowalany-Kozielska E; Wodniecki J; Tendera M; Poloński L
    Kardiol Pol; 1987; 30(7):409-18. PubMed ID: 3316787
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of verapamil on the indicators of left-ventricular diastole in hypertrophic cardiomyopathy].
    Dabrowski M; Górecka B; Witkowski A; Jodkowski J; Woroszylska M; Ruzyłło W
    Kardiol Pol; 1986; 29(5-6):345-55. PubMed ID: 3784250
    [No Abstract]   [Full Text] [Related]  

  • 8. [Personal experience with the long-term administration of verapamil in hypertrophic cardiomyopathies].
    Gregor P; Widimský P; Cervenka V; Vísek V; Dvorák J; Sládková T
    Vnitr Lek; 1986 Dec; 32(12):1179-87. PubMed ID: 3824917
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of verapamil on the left ventricular function in hypertrophic obstructive cardiomyopathy].
    Guo HS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Mar; 12(1):13-6. PubMed ID: 6540163
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypertrophic occlusive cardiomyopathy.
    Kaltenbach M; Hopf R
    Clin Invest Med; 1980; 3(1-2):179-84. PubMed ID: 7008998
    [No Abstract]   [Full Text] [Related]  

  • 11. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy.
    Rosing DR; Kent KM; Maron BJ; Condit J; Epstein SE
    Clin Invest Med; 1980; 3(1-2):195-203. PubMed ID: 7009000
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypertrophic cardiomyopathy: an overview.
    Epstein SE; Maron BJ
    Clin Invest Med; 1980; 3(1-2):185-93. PubMed ID: 7008999
    [No Abstract]   [Full Text] [Related]  

  • 13. [Systolic times of the left ventricle in hypertrophic obstructive cardiomyopathy: effects of beta-adrenergic stimulation and blocking].
    Giovannini E; Ferrari O; Pace F; Milazzotto F
    Boll Soc Ital Cardiol; 1975; 20(11):1595-600. PubMed ID: 1241953
    [No Abstract]   [Full Text] [Related]  

  • 14. [Left ventricular relaxation in hypertrophic cardiomyopathy and possibilities of controlling it with verapamil].
    Gregor P; Widimský P; Cervenka V; Vísek V; Sládková T; Dvorák J
    Cas Lek Cesk; 1987 Mar; 126(11):330-4. PubMed ID: 3829106
    [No Abstract]   [Full Text] [Related]  

  • 15. Verapamil, syncope, and hypertrophic obstructive cardiomyopathy.
    Trohman RG; Feldman T; Palomo AR; Kessler KM; Myerberg RJ
    N Engl J Med; 1986 Jun; 314(24):1583. PubMed ID: 3713755
    [No Abstract]   [Full Text] [Related]  

  • 16. [Echocardiographic parameters in hypertrophic cardiomyopathy during verapamil treatment (author's transl].
    Lemke R; Hopf R; Kober G; Kaltenbach M
    Z Kardiol; 1980 Oct; 69(10):661-8. PubMed ID: 7192909
    [No Abstract]   [Full Text] [Related]  

  • 17. [Calcium antagonists in hypertrophic cardiomyopathy].
    Nartowicz E; Ukleja-Adamowicz M
    Pol Tyg Lek; 1988 Oct; 43(44):1395-8. PubMed ID: 3252203
    [No Abstract]   [Full Text] [Related]  

  • 18. [Reduction of coronary artery cross section during conservative therapy of hypertrophic obstructive cardiomyopathy].
    Kaltenbach M; Hopf R; Petersen Y; Kober G
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():358-9. PubMed ID: 565994
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardio-selective beta-adrenergic therapy in a patient with asthma and hypertrophic obstructive cardiomyopathy.
    Smith SC; Spector SL
    Chest; 1981 Jul; 80(1):103-5. PubMed ID: 7195790
    [No Abstract]   [Full Text] [Related]  

  • 20. [Does verapamil affect the thickness of the cardiac muscle in hypertrophic cardiomyopathy?].
    Gregor P; Widimský P; Cervenka V; Vísek V; Sládková T; Dvorák J
    Vnitr Lek; 1986 Dec; 32(12):1188-96. PubMed ID: 3824918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.